HMGCR and adenomyosis: These results suggest that statins (targeting HMGCR) may provide some protective effect against menorrhagia caused by uterine fibroids, adenomyosis, or functional abnormalities, while monoclonal antibodies like evolocumab (targeting PCSK9) may increase the risk of infertility.